XML 105 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2019
Mar. 31, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Dec. 31, 2018
Operating activities:            
Net income $ 28.4   $ 21.7 $ 78.7 $ 61.5  
Adjustments to reconcile net income to net cash provided by operating activities:            
Depreciation and amortization       30.1 27.0  
Deferred financing costs       0.3 0.3  
Deferred gain       0.0 (1.4) $ (1.9)
Stock-based compensation expense       5.9 5.8  
Pension expense, net of funding       (0.1) (7.6)  
Changes in fair value of contingent consideration and deferred payment       0.8 0.8  
Payments for acquisition-related activity       (3.1) 0.0  
Deferred income taxes       8.6 1.8  
Changes in operating assets and liabilities       (62.6) (16.4)  
Net cash provided by operating activities       58.6 71.8  
Investing activities:            
Purchases of properties and equipment       (21.2) (10.1)  
(Payments for) proceeds from acquisition-related activity       (49.6) 3.0  
Other, net       0.5 0.0  
Net cash used for investing activities       (70.3) (7.1)  
Financing activities:            
Increase (decrease) in revolving lines of credit, net       37.5 (53.6)  
Payments of debt financing fees       (1.0) 0.0  
Purchases of treasury stock       (1.0) 0.0  
Redemptions of common stock to satisfy withholding taxes related to stock-based compensation       (1.9) (0.4)  
Payments for acquisition-related activity       (10.3) 0.0  
Cash dividends paid to stockholders (4.9) $ (4.8) (4.8) (14.5) (13.8)  
Proceeds from stock-based compensation activity       1.7 1.1  
Other, net       0.0 0.1  
Net cash provided by (used for) financing activities       10.5 (66.6)  
Effects of foreign exchange rate changes on cash and cash equivalents       (0.3) (0.6)  
Decrease in cash and cash equivalents       (1.5) (2.5)  
Cash and cash equivalents at beginning of year   $ 37.4   37.4 37.5 37.5
Cash and cash equivalents at end of period $ 35.9   $ 35.0 $ 35.9 $ 35.0 $ 37.4